Abstract
The pharmacokinetics of oral fleroxacin were compared in men and premenopausal women. The total volume of distribution of the drug was significantly smaller in women in the single-dose trial. No difference in other pharmacokinetic parameters was noted. Since adverse events appear to occur in women more commonly than in men, dose-response studies of fleroxacin in women may be appropriate.
Full Text
The Full Text of this article is available as a PDF (151.2 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Arcieri G., Griffith E., Gruenwaldt G., Heyd A., O'Brien B., Screen P., Becker N., August R. A survey of clinical experience with ciprofloxacin, a new quinolone antimicrobial. J Clin Pharmacol. 1988 Feb;28(2):179–189. doi: 10.1002/j.1552-4604.1988.tb05741.x. [DOI] [PubMed] [Google Scholar]
- Bauer L. A., Gibaldi M. Computation of model-independent pharmacokinetic parameters during multiple dosing. J Pharm Sci. 1983 Aug;72(8):978–979. doi: 10.1002/jps.2600720843. [DOI] [PubMed] [Google Scholar]
- Bertino J. S., Jr, Nafziger A. N., Wong M., Stragand L., Puleo C. Effect of a fat- and calcium-rich breakfast on pharmacokinetics of fleroxacin administered in single and multiple doses. Antimicrob Agents Chemother. 1994 Mar;38(3):499–503. doi: 10.1128/aac.38.3.499. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cockcroft D. W., Gault M. H. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31–41. doi: 10.1159/000180580. [DOI] [PubMed] [Google Scholar]
- Fischman A. J., Livni E., Babich J., Alpert N. M., Liu Y. Y., Thom E., Cleeland R., Prosser B. L., Correia J. A., Strauss H. W. Pharmacokinetics of [18F]fleroxacin in healthy human subjects studied by using positron emission tomography. Antimicrob Agents Chemother. 1993 Oct;37(10):2144–2152. doi: 10.1128/aac.37.10.2144. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Perrier D., Mayersohn M. Noncompartmental determination of the steady-state volume of distribution for any mode of administration. J Pharm Sci. 1982 Mar;71(3):372–373. doi: 10.1002/jps.2600710332. [DOI] [PubMed] [Google Scholar]
- Shah A., Lettieri J., Nix D., Wilton J., Heller A. H. Pharmacokinetics of high-dose intravenous ciprofloxacin in young and elderly and in male and female subjects. Antimicrob Agents Chemother. 1995 Apr;39(4):1003–1006. doi: 10.1128/aac.39.4.1003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wolfhagen M. J., Hoepelman A. I., Verhoef J. Double-blind, dose-range-finding study of fleroxacin (RO 23-6240; AM-833) for treatment of complicated urinary tract infections. Antimicrob Agents Chemother. 1990 Mar;34(3):409–412. doi: 10.1128/aac.34.3.409. [DOI] [PMC free article] [PubMed] [Google Scholar]